The validity of Tumor Mutation Burden (TMB) as a biomarker

The validity of Tumor Mutation Burden (TMB) as a biomarker

obr

1 year
42 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Joan Schiller, MD, shares the validity of Tumor Mutation Burden (TMB) as a biomarker at Annual Meeting 2018.
Up Next Autoplay